That's the sound of yesterday's Report dropping on 100s of desks all over the world ... pharmas, fund managers, cancer support groups, leading cancer specialists etc. Throughout the Report the word licencing is used so it's probably safe to assume that selling the business is now off the table and given our new offices in San Diego it's hard to believe a trip to Nasdaq is not now on the cards. My bet is that Chiplin is going to start getting calls from some big-time movers and shakers wanting… Read More
Great rise for them in there BUT as SAR has an agreement with CRT it only receives 27;5% of payments so a lot less than some people are claiming. A lot of folk think doing a deal with likes of CRT is not dilutive but it is as this shows.As SCLP has retained full IP protection and ownership of platforms it gets 100% of any future deal unless it chooses to partner in the meantime
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.